Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

92.91
-0.1200-0.13%
Post-market: 92.910.00000.00%19:30 EDT
Volume:11.40K
Turnover:1.06M
Market Cap:403.23M
PE:51.81
High:93.97
Open:93.28
Low:92.77
Close:93.03
52wk High:98.82
52wk Low:67.69
Shares:4.34M
Float Shares:4.34M
Volume Ratio:1.07
T/O Rate:0.26%
Dividend:1.54
Dividend Rate:1.66%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.63
PE(LYR):4.98

Loading ...

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Alnylam Pharmaceuticals Inc Stock (ALNY) Moved Up by 7.90% on Sep 2: Facts Behind the Movement

TradingKey
·
Sep 03

Political and General News Events from September 2

Reuters
·
Sep 02

Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

Reuters
·
Sep 02

Alnylam to Webcast Investor Conference Presentations in September

Reuters
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 02

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.
·
Sep 02

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Reuters
·
Sep 02

Investors Shrug Off Good News for Heart Patients from New Meds

Dow Jones
·
Sep 02

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live
·
Sep 01

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

TIPRANKS
·
Sep 01

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Reuters
·
Sep 01

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS
·
Sep 01

UK Regulator Suspends Avacopan Vifor for New Patients

MT Newswires Live
·
Sep 01